戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 atelet aggregation was measured by impedance aggregometry.
2 luding flow cytometry and light transmission aggregometry.
3            Platelet function was measured by aggregometry.
4  with VerifyNow-P2Y12 and light transmission aggregometry.
5  VerifyNow-P2Y12, but not light transmission aggregometry.
6 s differences in IC(5)(0) values obtained by aggregometry.
7 nders were identified by light transmittance aggregometry.
8 gation at 6 h assessed by light-transmission aggregometry.
9 ns and measured response by ex vivo platelet aggregometry.
10 eline and steady state by light-transmission aggregometry.
11 ggregation (PA) was assessed by conventional aggregometry.
12 very of platelet function than turbidimetric aggregometry.
13 id, ADP, collagen, or epinephrine by optical aggregometry.
14 osine diphosphate-induced light transmission aggregometry (11.6% relative increase in maximal platele
15 gregation between groups (multiple electrode aggregometry, 17.6+/-7.2 versus 18.1+/-6 U; P=0.281).
16 2 reaction units [PRU]), light transmittance aggregometry (adenosine diphosphate 5 and 20 mumol/l and
17                          Light transmittance aggregometry (adenosine diphosphate 5 to 20 muM), Verify
18 imuli were assessed with light transmittance aggregometry and defined patients with high post-treatme
19 -deficient platelets were confirmed via lumi-aggregometry and FACS analysis for P-selectin and LAMP-1
20 elets, as determined by whole blood platelet aggregometry and flow cytometric analysis of the platele
21                        Whole blood impedance aggregometry and flow cytometry evaluated platelet aggre
22                                     Platelet aggregometry and flow cytometry in a subset of subjects
23                                              Aggregometry and flow cytometry were used to assess plat
24       Neutrophil aggregation was measured by aggregometry and leukergy.
25 gation was measured using multiple electrode aggregometry and standard light transmission aggregometr
26 ion than patients without ischemic events by aggregometry and TEG (p < 0.001 for both measurements).
27 treatment platelet reactivity as measured by aggregometry and TEG were the only variables significant
28 treatment platelet reactivity at baseline by aggregometry and TEG, respectively.
29 telet Analyzer (CPA), with in vitro platelet aggregometry and the Rapid Platelet Function Assay (RPFA
30 ion measured by standard light transmittance aggregometry and thrombelastography (TEG) will be at inc
31 latelet reactivity measured by turbidometric aggregometry and thrombin-induced platelet-fibrin clot s
32 tivation of platelets by CRP and collagen in aggregometry and thrombus formation by the latter in who
33  1 h, 4 h, and 24 h using light transmission aggregometry and vasodilator-stimulated phosphoprotein p
34 imulated phosphoprotein, light transmittance aggregometry, and Multiplate were similar between prasug
35 imulated phosphoprotein, light transmittance aggregometry, and Multiplate, which allowed us to explor
36 we have developed a miniaturized whole blood aggregometry assay, based on a readily accessible 96-wel
37  aggregation (20 muM) by light transmittance aggregometry at 1 week (primary end point) was lower aft
38 latelet reactivity was assessed by impedance aggregometry before loading (intrinsic platelet reactivi
39 nction was shown by flow cytometry, platelet aggregometry, bleeding assays, and intravital imaging of
40                                     In vitro aggregometry confirmed that sildenafil rendered platelet
41 tomic force microscopy (small contact zone), aggregometry (discrete interactions), micropipette manip
42 function was monitored with the CPA and with aggregometry for up to 1 week after abciximab administra
43  diphosphate was measured with turbidimetric aggregometry in both D-phenylalanyl-L-prolyl-L-arginine
44 optimization of older tests such as platelet aggregometry, in addition to better defining the role of
45        Platelet-rich plasma was obtained for aggregometry induced by collagen (1 to 10 micrograms/ml)
46 aggregometry and standard light transmission aggregometry just before the switch and at 2, 6, 24, and
47 ine diphosphate (ADP) by light transmittance aggregometry (LTA) in patients undergoing PCI (n = 192).
48                           Light transmission aggregometry (LTA) is used worldwide for the investigati
49           Assays included light transmission aggregometry (LTA), VerifyNow P2Y12 (VN), and vasodilato
50           Assays included light transmission aggregometry (LTA), VerifyNow P2Y12 (VN-P2Y12), and vaso
51 tery disease (CAD) using light transmittance aggregometry (LTA), VerifyNow, platelet function analyze
52 efects in comparison with light transmission aggregometry (LTA).
53 egation was measured with light transmission aggregometry (LTA); platelet activation was assessed by
54 2 (P(2)Y(1)(2)) assay and multiple electrode aggregometry (MEA).
55 were assessed by means of light transmission aggregometry of suspensions with varying ratios of plate
56         Over 5 years, we have performed lumi-aggregometry on 9 platelet agonists in 111 unrelated res
57 platelet aggregation was assessed by optical aggregometry on day 1 and at 4-week intervals.
58  is more severe in LAD-III patients, classic aggregometry or perfusion of Glanzmann or LAD-III platel
59 ntage of free GP IIb/IIIa receptors than was aggregometry or the RPFA.
60 ost-dose, as measured by light transmittance aggregometry or vasodilator-stimulated phosphoprotein as
61  NAC thrombolytic effect, including platelet aggregometry, platelet-rich thrombi lysis assays, thromb
62 gregation was evaluated by in vitro platelet aggregometry (Protocol 3).
63 e studied with Fura-2 and light transmission aggregometry, respectively.
64         The mean maximum light transmittance aggregometry responses (adenosine diphosphate 20 muM) po
65                    Ex vivo, the CPA, but not aggregometry, showed prolonged platelet inhibition with
66 ated platelet function assessed by classical aggregometry, single-particle counting, granule secretio
67 , imatinib produce abnormalities in platelet aggregometry testing.
68                    When assessed by platelet aggregometry, the disruption of the lysin gene in SF100
69                     Using light transmission aggregometry, the extent of aggregation induced by plate
70  days, and 14 days using light transmittance aggregometry, VerifyNow P2Y(12) assay, and vasodilator-s
71 schemic risk measured by light transmittance aggregometry, VerifyNow P2Y(12) assay, and vasodilator-s
72  difference in measurements between RPFA and aggregometry was -4% (+/-4% SD), and the mean difference
73 utant mice, whereas platelet shape change in aggregometry was attenuated.
74          Neutrophil aggregation, measured by aggregometry, was increased in SS patients, 16 +/- 4% (p
75 results were found using light transmittance aggregometry with 5 muM adenosine diphosphate, VerifyNow
76 t fibrinogen binding, and light transmission aggregometry with ADP 5 and 10 mumol/l recorded at maxim

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。